» Articles » PMID: 25899394

Stem Cell Factor is Essential for Preserving NOD/SCID Reconstitution Capacity of Ex vivo Expanded Cord Blood CD34(+) Cells

Overview
Journal Cell Prolif
Date 2015 Apr 23
PMID 25899394
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Stem cell factor (SCF) is essential in the haematopoietic stem cells (HSCs) niche, and is therefore used extensively in haematopoietic stem and progenitor cells (HSPCs) ex vivo expansion. However, in the literature, dose and schedule of SCF feeding varies widely. We previously proposed a novel SCF feeding regimen with proven effectiveness for HSPCs expansion; however, physiological function of expanded cells with this SCF feeding regimen required further research.

Materials And Methods: CD34(+) cells were cultured with or without SCF supplementation in serum-free medium for 10 days. Expanded cells were transplanted into sublethally irradiated non-obese diabetic/severe combined immune-deficient (NOD/SCID) mice. Engraftment and multilineage reconstitution of transplanted cells were determined. Also, clonogenic potential of engrafted cells was analysed.

Results: Cells, both cultured with and without SCF supplementation, successfully engrafted and reconstituted blood cell lineages in NOD/SCID mice. However, level of engraftment and multilineage reconstitution reduced when cells were expanded without SCF supplementation. Meanwhile, frequencies of colony-forming cells (CFCs) amongst bone marrow cells were higher in mice transplanted with CD34(+) cells expanded with SCF supplementation.

Conclusions: Reconstitution capacity reduced when CD34(+) cells were expanded without SCF supplementation, though this feeding regimen did not have any effect on cell expansion. This finding suggested that SCF was essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded CD34(+) cells.

Citing Articles

A Customized Self-Assembling Peptide Hydrogel-Wrapped Stem Cell Factor Targeting Pulp Regeneration Rich in Vascular-Like Structures.

Mu X, Shi L, Pan S, He L, Niu Y, Wang X ACS Omega. 2020; 5(27):16568-16574.

PMID: 32685822 PMC: 7364552. DOI: 10.1021/acsomega.0c01266.


Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.

Li Q, Zhao D, Chen Q, Luo M, Huang J, Yang C Stem Cell Res Ther. 2019; 10(1):376.

PMID: 31806004 PMC: 6894464. DOI: 10.1186/s13287-019-1502-8.


Sustained release of stem cell factor in a double network hydrogel for ex vivo culture of cord blood-derived CD34 cells.

Zhang Y, Pan X, Shi Z, Cai H, Gao Y, Zhang W Cell Prolif. 2017; 51(2):e12407.

PMID: 29143396 PMC: 6528907. DOI: 10.1111/cpr.12407.


Curved microstructures promote osteogenesis of mesenchymal stem cells via the RhoA/ROCK pathway.

Zhang Q, Lin S, Zhang T, Tian T, Ma Q, Xie X Cell Prolif. 2017; 50(4).

PMID: 28714177 PMC: 6529063. DOI: 10.1111/cpr.12356.

References
1.
Kikushige Y, Yoshimoto G, Miyamoto T, Iino T, Mori Y, Iwasaki H . Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival. J Immunol. 2008; 180(11):7358-67. DOI: 10.4049/jimmunol.180.11.7358. View

2.
Du Z, Cai H, Ye Z, Tan W . Optimization of SCF feeding regimen for ex vivo expansion of cord blood hematopoietic stem cells. J Biotechnol. 2012; 164(2):211-9. DOI: 10.1016/j.jbiotec.2012.08.007. View

3.
Tursky M, Collier F, Ward A, Kirkland M . Systematic investigation of oxygen and growth factors in clinically valid ex vivo expansion of cord blood CD34(+) hematopoietic progenitor cells. Cytotherapy. 2012; 14(6):679-85. DOI: 10.3109/14653249.2012.666851. View

4.
Sitnicka E, Buza-Vidas N, Larsson S, Nygren J, Liuba K, Jacobsen S . Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells. Blood. 2003; 102(3):881-6. DOI: 10.1182/blood-2002-06-1694. View

5.
Andrade P, Dos Santos F, Cabral J, da Silva C . Stem cell bioengineering strategies to widen the therapeutic applications of haematopoietic stem/progenitor cells from umbilical cord blood. J Tissue Eng Regen Med. 2013; 9(9):988-1003. DOI: 10.1002/term.1741. View